Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Rheumatology

Does SAPHO Syndrome Cause Cancer or Raise Bone Cancer Risk?

At a Glance

SAPHO syndrome is not known to turn into cancer or increase overall cancer risk. Its inflammatory bone lesions can resemble bone tumors or cancer that has spread to bone on scans, so new, changing, or unusual lesions may need specialist review and sometimes a carefully planned biopsy.

No, SAPHO syndrome is not known to undergo malignant transformation (turn into cancer), nor is it considered a cancer predisposition syndrome. While long-term data on this rare condition are limited, current medical literature does not show any established link or increased overall risk of developing cancer [1][2]. Although the inflammatory bone lesions seen in SAPHO can sometimes look aggressive or destructive on imaging scans, they are fundamentally caused by inflammation rather than malignant cell growth [3][4].

(Note: This page addresses the risk of cancer from SAPHO syndrome itself, not the separate benefits and risks of any specific medications you may take to manage the condition.)

Why SAPHO Can Look Like Cancer

To understand why SAPHO lesions can raise alarms, it helps to distinguish between a primary bone cancer (a cancer that starts in the bone) and bone metastases (cancer that has spread to the bone from another organ). SAPHO lesions can mimic both.

Because SAPHO syndrome causes active inflammation in the bones (osteitis) and abnormal bone overgrowth (hyperostosis), the resulting lesions can sometimes mimic the appearance of bone tumors [4]. On imaging tests like X-rays, MRIs, or PET scans, early SAPHO lesions may cause areas of bone breakdown (osteolysis) or increased metabolic activity [3]. It is important to know that PET and bone scans are nonspecific—they light up to show areas of high activity, which can be caused by active inflammation, infection, or cancer alike, and they generally cannot make that distinction on their own.

Over time, SAPHO lesions often develop a mixed pattern of bone breakdown and hardening (sclerosis), which can strongly resemble certain types of bone metastases [5]. Additionally, SAPHO can involve soft-tissue swelling around the affected bones, further mimicking a tumor [6]. However, these changes are part of the inflammatory process of SAPHO and do not indicate that the condition is turning into cancer [4].

When Is Further Evaluation Needed?

Even though SAPHO itself does not turn into cancer, a person with SAPHO can still develop an unrelated tumor just like anyone else [2][7]. Because of this, it is critical that any new, unusual, or changing bone lesion is evaluated carefully by your care team, which may include rheumatologists, radiologists, and orthopedic oncology specialists.

Your doctor may recommend a biopsy (taking a small sample of tissue for testing) if a bone lesion:

  • Is solitary, purely destructive, or progressively worsening [4][8].
  • Presents with a rapidly enlarging soft-tissue mass or causes a bone fracture [8][6].
  • Differs from your overall clinical pattern or imaging history [9]. While SAPHO most commonly involves the anterior chest wall and spine, it can also affect the jaw, pelvis, and long bones; location alone does not dictate whether a lesion is atypical.
  • Occurs if you have a personal history of cancer, as malignancies can occasionally mimic SAPHO lesions or coexist with them [2][7].

In many cases, the combination of your clinical history (such as associated skin issues) and characteristic imaging patterns (such as the “bull’s-head” sign on a bone scan) can strongly support a SAPHO diagnosis and reduce the need for a biopsy [10][11]. However, these signs are not present in everyone and do not definitively rule out cancer or infection on their own. If the pattern changes or behaves unexpectedly, revisiting the diagnosis is a necessary safety measure to rule out other conditions [12][4].

If a biopsy is needed, it should be carefully planned by an appropriate specialist, such as a musculoskeletal radiologist or orthopedic oncologist, to ensure it is done safely and accurately [8].

Safety Guidance and Imaging

There is no single, universal imaging schedule for SAPHO syndrome. Repeat imaging should be individualized based on your symptoms, lesion location, and treatment response. Unnecessary routine scans can expose you to extra radiation and anxiety without clearly distinguishing active SAPHO from other issues.

When to Contact Your Doctor Promptly:
You should reach out to your medical team before your next scheduled appointment if you experience:

  • Rapidly worsening pain or an inability to bear weight.
  • A new or rapidly enlarging swelling or mass.
  • New weakness, numbness, or tingling.
  • Unexplained fever or feeling acutely ill.

Note: Having these symptoms does not mean you have cancer. Night pain and fevers can occur with SAPHO flares or infections, but they always warrant prompt specialist assessment to ensure the correct diagnosis.

Common questions in this guide

Can SAPHO syndrome turn into cancer?
No. Current evidence does not show that SAPHO syndrome turns into cancer or is a cancer-predisposition condition. The bone changes seen in SAPHO are caused by inflammation and abnormal bone growth rather than cancer cells.
Why can SAPHO lesions look like bone cancer on an imaging scan?
Inflammation and abnormal bone growth can cause bone breakdown, hardening, increased activity on PET or bone scans, and nearby soft-tissue swelling. These findings can resemble a primary bone tumor or cancer that has spread to bone, and scans alone may not distinguish inflammation, infection, and cancer.
When would a person with SAPHO need a biopsy?
A biopsy may be considered when a lesion is solitary, purely destructive, progressively worsening, associated with a rapidly enlarging mass or fracture, or unlike the person's usual SAPHO pattern. A personal history of cancer can also make further evaluation especially important. If needed, the biopsy should be planned by an appropriate specialist, such as a musculoskeletal radiologist or orthopedic oncologist.
Does every new SAPHO lesion require a biopsy or regular scans?
No. A familiar clinical and imaging pattern may support SAPHO without a biopsy, and there is no single imaging schedule for everyone. Repeat imaging should be based on symptoms, lesion location, treatment response, and whether the pattern changes.
What symptoms should prompt a person with SAPHO to call the doctor?
Contact your medical team promptly for rapidly worsening pain, inability to bear weight, a new or quickly enlarging swelling or mass, new weakness or numbness, or unexplained fever and feeling acutely ill. These symptoms do not prove cancer, but they need timely assessment to check for SAPHO activity, infection, or another condition.
Can SAPHO medicines affect cancer or serious infection risk?
This page addresses the cancer risk of SAPHO itself, not the separate benefits and risks of specific medicines. The effects vary by medication and by the person's health history, so ask the prescribing clinician about cancer and serious infection risks for your treatment.

Get notified when new evidence is published on SAPHO syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) Syndrome Mimicking Bone Metastases in the Spine: A Presentation of Two Cases and Literature Review.

    Rolemberg Dantas FL, Dantas F, Tscherbakowski Nunes de Guimarães Mourão R, et al.

    Cureus 2024; (16(7)):e64974 doi:10.7759/cureus.64974.

    PMID: 39161490
  2. 2

    Metastatic Carcinoma of Prostate as a Mimicker of SAPHO Syndrome.

    Sehgal R, Virata AR, Bansal P, Hart M

    Clinical medicine & research 2021; (19(3)):141-147 doi:10.3121/cmr.2021.1539.

    PMID: 33985979
  3. 3

    FDG PET/CT in Early and Late Stages of SAPHO Syndrome: Two Case Reports With MRI and Bone Scintigraphy Correlation.

    Dong A, Bai Y, Cui Y, et al.

    Clinical nuclear medicine 2016; (41(4)):e211-5 doi:10.1097/RLU.0000000000000983.

    PMID: 26359576
  4. 4

    Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome with Purely Osteolytic, Not Osteosclerotic, Lesions Mimicking a Malignant Tumor.

    Kinoshita H, Ishii T, Kamoda H, et al.

    Case reports in rheumatology 2020; (2020()):6316921 doi:10.1155/2020/6316921.

    PMID: 32280553
  5. 5

    F-18 FDG PET/CT in 26 patients with SAPHO syndrome: a new vision of clinical and bone scintigraphy correlation.

    Sun X, Li C, Cao Y, et al.

    Journal of orthopaedic surgery and research 2018; (13(1)):120 doi:10.1186/s13018-018-0795-0.

    PMID: 29788984
  6. 6

    Diagnostic value of ultrasonography in synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome: A case report.

    Asano T, Furuya MY, Fujita Y, et al.

    Medicine 2018; (97(41)):e12725 doi:10.1097/MD.0000000000012725.

    PMID: 30313072
  7. 7

    A Case Requiring Differential Diagnosis of Synovitis, Acne, Pustulosis, Hyperostosis, Osteomyelitis Syndrome in the Evaluation of Bone Lesions in Early Breast Cancer.

    Mori M, Kikuchi M, Miyabe R, et al.

    Surgical case reports 2026; (12(1)) doi:10.70352/scrj.cr.25-0822.

    PMID: 42052148
  8. 8

    Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome.

    Schaub S, Sirkis HM, Kay J

    Rheumatic diseases clinics of North America 2016; (42(4)):695-710 doi:10.1016/j.rdc.2016.07.011.

    PMID: 27742022
  9. 9

    An Unusual Bone Metastasis Mimicking SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis) Syndrome on Bone Scintigraphy.

    Ni J, Tang P

    Clinical nuclear medicine 2016; (41(2)):173-5 doi:10.1097/RLU.0000000000001061.

    PMID: 26505860
  10. 10

    Pro and contra: is synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) a spondyloarthritis variant?

    Furer V, Kishimoto M, Tomita T, et al.

    Current opinion in rheumatology 2022; (34(4)):209-217 doi:10.1097/BOR.0000000000000884.

    PMID: 35699334
  11. 11

    SAPHO and CRMO: The Value of Imaging.

    Jurik AG, Klicman RF, Simoni P, et al.

    Seminars in musculoskeletal radiology 2018; (22(2)):207-224 doi:10.1055/s-0038-1639469.

    PMID: 29672809
  12. 12

    A Case of Atypical Synovitis-Acne-Pustulosis-Hyperostosis-Osteitis (SAPHO) Syndrome Presenting With Osteomyelitis of the Clavicle.

    Sharma C, Chow B

    WMJ : official publication of the State Medical Society of Wisconsin 2017; (116(2)):87-88.

    PMID: 29323824

This page is for informational purposes only and does not constitute medical advice. It explains cancer-risk questions and imaging concerns in SAPHO syndrome; discuss changing symptoms or lesions with your rheumatologist and care team.